Abstract
Elderly patients represent an important subgroup in primary central nervous system lymphoma (PCNSL) that accounts for approximately half the cases. Furthermore age represents one of the heaviest prognostic factors and in some cases it has more effect on survival than therapies. We performed a retrospective analysis to assess the toxicity and the efficacy of high-dose methotrexate (HDMTX) chemotherapy in a PCNSL population older than 70 years. Seventeen consecutive immunocompetent patients older than 70 years, with histologically confirmed PCNSL, without systemic involvement, treated with HDMTX at our institution between May 2005 and April 2013, were retrospectively evaluated. Main outcome measures were acute toxicity and tumour response. No evidence of haematological toxicity was recorded in 47 % of patients and no deaths related to toxicity grade were reported. Patients achieved a partial response after 3 cycles of chemotherapy in 53 % of cases. The median overall survival (m-OS) from diagnosis was 20.9 months (range 5.2–34 months), with OS-12 of 58.8 % and an OS-24 of 45.4 %. Since there is no standard of care in the treatment of PCNSL in elderly population, it should be taken into account that elderly patients not always can be considered “fragile” and the general tendency to less treat to avoid severe toxicity should not be the rule.
References
Ferreri AJ, Marturano E (2012) Primary CNS lymphoma. Best Pract Res Clin Haematol 25(1):119–130. doi:10.1016/j.beha.2011.12.001
Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE (2010) Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer 116(19):4605–4612. doi:10.1002/cncr.25363
Charlson M, Szatrowski TP, Peterson J et al (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251
Latta S, Cygan PH, Fried W, Nabhan C (2013) Diffuse large B-cell non-Hodgkin lymphoma in the very elderly: challenges and solutions. Oncology (Williston Park) 27(2):126–130 (132–136, 138)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Gaviani, P., Simonetti, G., Innocenti, A. et al. Safety and efficacy of primary central nervous system lymphoma treatment in elderly population. Neurol Sci 37, 131–133 (2016). https://doi.org/10.1007/s10072-015-2371-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2371-2